Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 984 entries
View as:

A Study to Evaluate the Bioequivalence (BE) and the Food Effect of TAK-438ASA Tablet

Phase: N/A Priority: Normal
NCT ID: NCT03456960 Org: User:
Start: 03/08/18 End: 10/12/18 Due: 10/12/19

Efficacy and Safety of TAK-559 Combined With Glyburide in Treating Subjects With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00759720 Org: User:
Start: 11/30/03 End: 12/31/04 Due: 12/31/05

A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India

Phase: N/A Priority: Normal
NCT ID: NCT06831370 Org: User:
Start: 08/28/24 End: 03/31/26 Due: 03/31/27

Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT02475278 Org: User:
Start: 02/26/15 End: 09/09/15 Due: 09/09/16

A Study of Brigatinib to Treat Adults With Anaplastic Lymphoma Kinase (ALK) Positive Metastatic Non Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT04887519 Org: User:
Start: 12/30/20 End: 03/31/23 Due: 03/31/24

Blood Sample Collection Study for Pharmacogenomic Characterization of Participants That Previously Received Namilumab in M1-1188-002-EM (PRIORA, [NCT01317797]) Study

Phase: N/A Priority: Normal
NCT ID: NCT02528786 Org: User:
Start: 11/19/15 End: 04/05/16 Due: 04/05/17

Wake and Sleep State Transitions on a Portable Electroencephalogram (EEG) Device in Narcolepsy Type 1 (NT1) and Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT04445129 Org: User:
Start: 08/03/20 End: 05/04/21 Due: 05/04/22

Effect of Febuxostat on Renal Function in Patients With Gout and Moderate to Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01082640 Org: User:
Start: 04/30/10 End: 05/31/12 Due: 05/31/13

A Phase 3 Comparative Study of TAP-144-SR(6M) in Prostate Cancer Patients Previously Treated With Hormonal Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01546623 Org: User:
Start: 03/31/12 End: 04/30/14 Due: 04/30/15

Efficacy of Alogliptin and With Pioglitazone in Patients With Type 2 Diabetes.

Phase: N/A Priority: Normal
NCT ID: NCT00655863 Org: User:
Start: 07/31/07 End: 12/31/09 Due: 12/31/10

Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>

Phase: N/A Priority: Normal
NCT ID: NCT02181842 Org: User:
Start: 01/26/09 End: 06/30/11 Due: 06/30/12

Study of TAK-816 in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT01379846 Org: User:
Start: 06/30/11 End: 02/28/13 Due: 02/28/14

A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01712490 Org: User:
Start: 11/09/12 End: 01/20/26 Due: 01/20/27

A Study to Determine the Bioequivalence of Alogliptin and Pioglitazone When Administered as Individual Tablets and as Fixed-Dose Combination (FDC)-SYR-322-4833 BL Tablets to Healthy Russian Participants

Phase: N/A Priority: Normal
NCT ID: NCT03501277 Org: User:
Start: 05/26/18 End: 07/11/18 Due: 07/11/19

Candesartan Cilexetil / Hydrochlorothiazide Combination Tablets Special Drug Use Surveillance: Long-term Use (12 Months)

Phase: N/A Priority: Normal
NCT ID: NCT02016183 Org: User:
Start: 04/01/09 End: 09/30/12 Due: 09/30/13

Lubiprostone for Chronic Idiopathic Constipation Treatment

Phase: N/A Priority: Normal
NCT ID: NCT02729909 Org: User:
Start: 05/11/16 End: 06/05/17 Due: 06/05/18

Alogliptin Tablets Special Drug Use Surveillance Type 2 Diabetes Mellitus: Combination Therapy With Biguanides

Phase: N/A Priority: Normal
NCT ID: NCT01964976 Org: User:
Start: 07/31/11 End: 12/31/14 Due: 12/31/15

An Open-label Study of Vedolizumab (MLN0002) in Participants With Ulcerative Colitis and Crohn's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00790933 Org: User:
Start: 05/22/09 End: 10/31/17 Due: 10/31/18

TAK-875 Glimepiride Drug-Interaction Study

Phase: N/A Priority: Normal
NCT ID: NCT01496443 Org: User:
Start: 01/31/12 End: 05/31/12 Due: 05/31/13

A Phase III Long-term Study of TAK-536TCH in Participants With Essential Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT02277691 Org: User:
Start: 11/07/14 End: 04/25/16 Due: 04/25/17

Pevonedistat Plus Azacitidine Versus Single-Agent Azacitidine as First-Line Treatment for Participants With Higher-Risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Low-Blast Acute Myelogenous Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT03268954 Org: User:
Start: 11/28/17 End: 10/14/24 Due: 10/14/25

A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection in Argentina

Phase: N/A Priority: Normal
NCT ID: NCT06213974 Org: User:
Start: 09/03/24 End: 09/01/26 Due: 09/01/27

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT00754403 Org: User:
Start: 07/31/05 End: 10/31/06 Due: 10/31/07

A Study of TAK-279 in Adult Participants With Generalized Pustular Psoriasis or Erythrodermic Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT06323356 Org: User:
Start: 03/19/24 End: 03/27/26 Due: 03/27/27

A Study of TAK-951 in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT06610279 Org: User:
Start: 01/07/22 End: 09/21/23 Due: 09/21/24